Testing effectiveness (Phase 2)Study completedNCT00551915
What this trial is testing
The Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)
Who this might be right for
Bacterial Infections; Virus Diseases
Merck Sharp & Dohme LLC 756